Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Plos One|June 10, 2015
Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic RiskMassimo Cugno, Alberto Tedeschi, Alessandro Borghi, et al.Microorganisms|June 24, 2022
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 PatientsMassimo Cugno, Pier Luigi Meroni, Dario Consonni, et al.Pediatric Nephrology (Berlin, Germany)|October 20, 2017
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an updateGianluigi Ardissino, Francesca Tel, Martina Sgarbanti, et al.Journal of the American Society of Nephrology : JASN|March 13, 2021
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic SyndromeMassimo Cugno, Silvia Berra, Federica Depetri, et al.Journal of Autoimmunity|January 16, 2021
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19Luca Valenti, Samantha Griffini, Giuseppe Lamorte, et al.Journal of Nephrology|January 27, 2024
Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibitionGianluigi Ardissino, Donata Cresseri, Maria Cristina Mancuso, et al.Internal and Emergency Medicine|November 8, 2025
Involvement of the contact pathway in COVID-19 coagulopathyMarco Capecchi, Cristina Novembrino, Maria Abbattista, et al.Haematologica|May 15, 2025
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamabGianluigi Ardissino, Piera Angelillo, Maria Cristina Mancuso, et al.Journal of Cardiovascular Pharmacology and Therapeutics|December 15, 2015
Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA TrialMehmet Özkan, Macit Kalçık, Mustafa Ozan Gürsoy, et al.Journal of Autoimmunity|September 30, 2021
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccinationMassimo Cugno, Paolo Macor, Mara Giordano, et al.Pageof 3